Effects of substance P on human T cell function and the modulatory role of peptidase inhibitors

International Journal of Clinical and Laboratory Research

Volumn 27, Issue 2, 1997, Pages 129-134

  Covas, M J ^a   Pinto, L A ^a   Victorino, R M M ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Dipeptidylpeptidase IV CD26; Neuroimmunomodulation; Neutral endopeptidase VD10; Substance P; T cell function

Indexed keywords

EID: 0030743874     PISSN: 09405437     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02912447     Document Type: Article

References (37)

1. Pernow B. Substance P. Pharmacol Rev 1983; 35:85.
2. Johnson HM, Downs MO, Pontzer CH. Neuroendocrine peptide hormone regulation of immunity. Chem Immunol 1992; 52:49.
3. Levine JD, Clark R, Devor M, Helmus C, Moskowitz MA, Basbaum A. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984; 226:547.
4. Mantyh CR, Gates TS, Zimmerman RP, Welton ML, Passaro EP, Vigma SR, Maggio JE, Kruger L, Mantyh P. Receptor binding sites for substance P but not substance K or neumedin K, are expressed in high concentrations by arterioles, venules, and lymph nodes in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci USA 1988; 85:3235.
5. Covas MJ, Pinto LA, Victorino RMM. Disturbed immunoregulatory properties of the neuropeptide substance P on lymphocyte proliferation in HIV infection. Clin Exp Immunol 1994; 96:384.
6. Marshal KW, Chiu B, Inman RD. Substance P and arthritis analysis of plasma and synovial fluid levels. Arthritis Rheum 1990; 37:87.
7. Azzari C, Rossi ME, Resti M, Caldini AL, Lega L, Galli L, Fico E, Vierucci A. Changed levels of substance P and somatostatin in HIV-positive children. Pediatr Med Chir 1992; 14:577.
8. Payan DG, Brewster DR, Missirian-Bastian A, Goetzel EJ, Substance P recognition by a subset of human T lymphocytes. J Clin Invest 1984; 74:1532.
9. Jeurissen F, Kavelaars A, Korstjens M, Brocke D, Franklin RA, Gelfand EW, Heijnen CJ. Monocytes express a non-neurokinin substance P receptor that is functionally coupled to Map kinase. J Immunol 1994; 152:2987.
10. Payan DG, Brewster DR, Goetzel EJ. Specific stimulation of human T lymphocytes by substance P. J Immunol 1983; 131:1613.
11. Stanisz AM, Befus D, Bienenstock J. Differential effects of vasoactive intestinal peptide, substance P and somatostatin on immunoglobulin synthesis and proliferation by lymphocytes from Peyer's Patches, mesenteric lymph nodes, and spleen. J Immunol 1986; 136:152.
12. Scicchitano R, Biennenstock J, Stanisz AM. In vivo immunomodulation by the neuropeptide substance P. Immunology 1988; 63:733.
13. Kavelaars A, Jeurissen F, Kunzel JFD, Von Roijen JH, Rijkers GT, Heijnen CJ. Substance P induces a rise in intracellular calcium concentration m human T lymphocytes in vitro: evidence of a receptor-independent mechanism. J Neuroimmunol 1993; 42:61.
14. Liping Z, Dan C, Shuzhen Z, Shilian L. Observation of the effect of substance P on human T and B lymphocyte proliferation. Immunol Commun 1984; 13:457.
15. Robert AI, Taunk J, Ebert EC. Human lymphocytes lack substance P receptors. Cell Immunol 1992; 141:457.
16. Rameshwar P, Gascon P, Ganea D. Stimulation of IL-2 production in murine lymphocytes by substance P related tachykinins. J Immunol 1993; 151:2484.
17. Nio DA, Moylan RN, Roche JK. Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements. J Immunol 1993; 150:5281.
18. Shipp MA, Stefano GB, D'Aamio L, Switzer SN, Howard FD, Sinisterra J, Scharrer A, Reinhertz EL. Downregulation of enkephalin mediated inflammatory responses by CD10/neutral endopeptidase 24.11. Nature 1990; 347:394.
19. Iwamoto I, Kimura A, Yamazaki H, Nakagawa N, Towioka H, Soshida S. Neutral endopeptidase modulates substance P induced activation of human neutrophils. Int Arch Allergy Appl Immunol 1990; 93:133.
20. Shipp MA, Stefano GB, Switzer SN, Griffin JD, Reinhertz EL. CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation. Blood 1991; 78:1834.
21. Stefano GB, Paemen LR, Hughes TK. Autoimmunoregulation: differential modulation of CD10/neutral endopeptidase 24.11 by tumor necrosis factor and neuropeptides. J Neuroimmunol 1992; 41:9.
22. Letarte M, Vera S, Tran R, Addis JB, Onizuka RJ, Quackenbush EJ, Jongeneel CV, McInnes RR. Common acute lymphoblastic leukemia antigen is identical to neutral endopeptidase. J Exp Med 1988; 168:1247.
23. Matsas R, Fucher IS, Kenny AJ, Turner AJ. Substance P and (Leu) enkephalin are hydrolyzed by an enzyme in pig caudate synaptic membranes that is identical with the endopeptidase of kidney microvilli. Proc Natl Acad Sci USA 1983; 80-3111.
24. Mari B, Checler F, Ponzio G, Peyron JF, Manie S, Farahifar D, Rossi B, Auberger P. Jurkat T cells express a functional neutral endopeptidase activity (CALLA) involved in T cell activation. EMBO J 1993; 11:3875.
25. Mattern T, Scholz W, Feller AC, Flad HD, Ulmer AJ. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocyles. Scand J Immunol 1991; 33:737.
26. Wang L, Ahmad S, Benter IF, Chow A, Mizutani S, Ward PE. Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme. Peptides 1991; 12:1357.
27. Schon E, Jahn S, Kieessig ST, Demuth HV, Neubert K, Barth A, Von Baehr R, Ansorge S. The role of dipeptidyl peptidase IV in human T lymphocyte activation. Inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur J Immunol 1987; 17:1821.
28. Reinhold DU, Bank F, Buhling K, Neubert T, Mattern AJ, Ulmer H, Flad D, Ansorge S. Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells and IL-2 and IL-6 production. Immunobiology 1993; 188:403.
29. Calvo CF, Chavanel G, Senik A. Substance P enhances IL-2 expression in activated human T cells. J Immunol 1992; 148:3498.
30. Laurenzi MA, Persson MAA, Dalgaard CJ, Ringden O. Stimulation of B lymphocyte differentiation by the neuropeptides substance P and neurokinin A. Scand J Immunol 1989; 30:695.
31. Lotz M, Vaughan JH, Carson DA. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241:1218.
32. Laurenzi MA, Persson MAA, Dalgaard CJ, Haegerstrand A. The neuropeptide substance P stimulates production of interleukin-1 in human blood monocytes: activated cells are perferentially influenced by the neuropeptide Scand J Immunol 1990; 31:529.
33. Heijnen CJ, Zijlstra J, Kavelaars A, Croiset G, Bailleur R. Modulation of the immune response by POMC-derived peptides. I. Influence on proliferation of human lymphocytes. Brain Behav Immun 1987; 1:284.
34. Millar DB, Hough CJ, Mazorow DL, Gootenberg. B-endorphin's modulation of lymphocyte proliferation is dose, donor, and time dependent. Brain Behav Immun 1990; 4:232.
35. Muscat C, Bertotto A, Agea E, Bistoni O, Ercolani R, Tognellini R, Spinozzi F, Cesarotti M, Gerli R. Expression and functional role of iF7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients. Clin Exp Immunol 1994; 98:252.
36. Blazquez MV, Madueno JA, Gonzalez R, Jurado R, Bachovchin WW, Pena J, Munoz E. Selective decrease of CD26 expression in T cells from HIV1 infected individuals. J Immunol 1992; 149:3073.
37. Covas MJ, Pinto LP, Pereira da Silva JA, Victorino RMM. Effects of the neuropeptide substance P on lymphocyte proliferation in rheumatoid arthritis. J Int Med Res 1995; 23:431.